There's More Good Vaccine News

Oxford-AstraZeneca's COVID-19 vaccine has average effectiveness of 70%
Posted Nov 23, 2020 12:01 AM CST
There's More Good Vaccine News
In this Thursday, April 23, 2020 file screen grab taken from video issued by Britain's Oxford University, showing a person being injected as part of the first human trials in the UK to test a potential coronavirus vaccine, untaken by Oxford University in England.   (Oxford University Pool via AP, File)

Another COVID-19 vaccine trial is reporting positive news: The vaccine developed by British pharmaceutical company AstraZeneca in collaboration with the University of Oxford is "highly effective" at preventing disease, the pharma giant says in a statement. The vaccine was found to have an average effectiveness of 70%, CNBC reports, with one of the two dosing regimens that were tested having an efficacy rate of 90%. Among those who got the vaccine, no hospitalizations or severe cases of COVID-19 were reported, the AP reports. It's the third vaccine since last week to report heartening results. (More coronavirus stories.)

Get the news faster.
Tap to install our app.
X
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.

X